Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Sikri, R. Chawla, R. Sardana, A. Jain (New Delhi, India). Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India. Eur Respir J 2012; 40: Suppl. 56, 2501

Member's Comments

No comment yet.

Related content which might interest you: Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Prognostic biomarkers in severe community-acquired pneumonia (SCAP) patients, requiring intensive care unit (ICU) admission Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Evaluation of severe pneumonias in the ICU of a tertiary center in Southern India Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017 Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 The study of the role of procalcitonin (PCT) in early detection of nosocomial infections in chest patients Source: Annual Congress 2008 - Mechanical ventilation and airway management Year: 2008 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Comparison of CPIS (clinical pulmonary infection score) and clinical criteria in the diagnosis of ventilator associated pneumonia in ICU complex patients Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007 Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003